Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic’s $270 Mil. SDC Artificial Disc Purchase Supplements Internal R&D

This article was originally published in The Gray Sheet

Executive Summary

Medtronic will continue its in-house artificial disc R&D program following the acquisition of Bryan cervical disc system developer Spinal Dynamics Corp. (SDC) as part of a two-pronged strategy to develop an alternative to spinal fusion devices for degenerative disc disease

You may also be interested in...



Lumbar Disc Developers Hold Their Own With Orthopedic Giants

Raymedica and Interpore Cross are readying internally-developed artificial spinal disc offerings for U.S. market entry behind J&J/DePuy Acromed, Medtronic/Sofamor Danek and Synthes-Stratec - three companies competing through recent acquisitions

Lumbar Disc Developers Hold Their Own With Orthopedic Giants

Raymedica and Interpore Cross are readying internally-developed artificial spinal disc offerings for U.S. market entry behind J&J/DePuy Acromed, Medtronic/Sofamor Danek and Synthes-Stratec - three companies competing through recent acquisitions

VCs Cite Early Planning As Key To Big Paydays On Device Startups

Enteric Medical and Spinal Dynamics Corp. (SDC) exemplify venture capital-backed firms sold to large medical device players for healthy returns on investment dollars, according to panelists at the Wilson Sonsini Goodrich & Rosati medical device meeting in San Jose, Calif. June 18-19

Related Content

UsernamePublicRestriction

Register

MT016806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel